Literature DB >> 17445796

Cardiac effects of L/N-type Ca2+ channel blocker cilnidipine in anesthetized dogs.

Akira Takahara1, Hiroshi Iwasaki, Yuji Nakamura, Atsushi Sugiyama.   

Abstract

Cardiac effects of L/N-type Ca2+ channel blocker cilnidipine were assessed using the halothane-anesthetized canine model. Cilnidipine (1 and 3 microg/kg, i.v.) lowered the mean blood pressure by -5 and -14 mm Hg, respectively, without affecting the heart rate or maximum upstroke velocity of left ventricular pressure. Isoproterenol or acetylcholine was intravenously injected to directly or indirectly induce the positive chronotropic responses, respectively. Cilnidipine hardly affected the isoproterenol-induced cardiac responses, but it attenuated the acetylcholine-induced reflex tachycardia to 63-78% of the pre-drug control level. These results suggest that clinically relevant doses of cilnidipine can directly attenuate the sympathetic tone.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17445796     DOI: 10.1016/j.ejphar.2007.03.025

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Long-term blockade of L/N-type Ca(2+) channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart.

Authors:  A Takahara; Y Nakamura; H Wagatsuma; S Aritomi; A Nakayama; Y Satoh; Y Akie; A Sugiyama
Journal:  Br J Pharmacol       Date:  2009-09-28       Impact factor: 8.739

2.  Comparison of direct effects of clinically available vasodilators; nitroglycerin, nifedipine, cilnidipine and diltiazem, on human skeletonized internal mammary harvested with ultrasonic scalpel.

Authors:  Shoji Fukuda; Yuji Nakamura; Koso Egi; Shunichiro Fujioka; Satoshi Nagasaka; Pham Ngoc Minh; Koji Toguchi; Takeshi Wada; Hiroko Izumi-Nakaseko; Kentaro Ando; Tetsuya Mizoue; Kenji Takazawa; Shigeru Hosaka; Atsushi Sugiyama
Journal:  Heart Vessels       Date:  2016-01-28       Impact factor: 2.037

3.  The effects of the L/N-type calcium channel blocker (cilnidipine) on sympathetic hyperactive morning hypertension: results from ACHIEVE-ONE.

Authors:  Kazuomi Kario; Shin-ichi Ando; Hidenori Kido; Jin Nariyama; Shin Takiuchi; Tetsuo Yagi; Toshiki Shimizu; Kazuo Eguchi; Minoru Ohno; Osamu Kinoshita; Takahisa Yamada
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-12-10       Impact factor: 3.738

4.  Effect of a novel calcium channel blocker on abnormal nocturnal blood pressure in hypertensive patients.

Authors:  Kazuomi Kario; Jin Nariyama; Hidenori Kido; Shin-ichi Ando; Shin Takiuchi; Kazuo Eguchi; Yawara Niijima; Toshiaki Ando; Makoto Noda
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-04-29       Impact factor: 3.738

5.  Comparison of the antialbuminuric effects of L-/N-type and L-type calcium channel blockers in hypertensive patients with diabetes and microalbuminuria: the study of assessment for kidney function by urinary microalbumin in randomized (SAKURA) trial.

Authors:  Katsuayuki Ando; Kenji Ueshima; Sachiko Tanaka; Shinji Kosugi; Tosiya Sato; Hiroaki Matsuoka; Kazuwa Nakao; Toshiro Fujita
Journal:  Int J Med Sci       Date:  2013-07-30       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.